20.11.2014 Views

LOMOPRIM DS Tablet - Lomus Pharmaceuticals Pvt. Ltd.

LOMOPRIM DS Tablet - Lomus Pharmaceuticals Pvt. Ltd.

LOMOPRIM DS Tablet - Lomus Pharmaceuticals Pvt. Ltd.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>LOMOPRIM</strong> <strong>DS</strong> <strong>Tablet</strong>/ <strong>Tablet</strong>/Suspension/ Drop<br />

Dosage Forms/Composition<br />

Cotrimoxazole<br />

<strong>DS</strong> <strong>Tablet</strong>: Each tablet contains Trimethoprim 160 mg and Sulphamethoxazole 800 mg<br />

<strong>Tablet</strong>: Each Lomorpim plain <strong>Tablet</strong> contains: Trimethoprim 80 mg and Sulphamethoxazole 400 mg<br />

Suspension: Each 5 mlcontains Trimethoprim 40 mg and Sulphamethoxazole 200 mg<br />

Drops: Each 2 ml contains Trimethoprim 40 mg and Sulphamethoxazole 200 mg<br />

Pharmacological Index<br />

Antibiotic, Sulfonamide Derivative<br />

INDICATION<br />

Oral treatment of urinary tract infections due to E. coli, Klebsiella and Enterobacter sp, M.<br />

morganii, P. mirabilis and P. vulgaris; acute otitis media in children and acute exacerbations<br />

of chronic bronchitis in adults due to susceptible strains of H. influenzae or S. pneumoniae;<br />

prophylaxis of Pneumocystis carinii pneumonitis (PCP), traveler's diarrhea due to<br />

enterotoxigenic E. coli or Cyclospora<br />

Unlabeled use: Cholera and salmonella-type infections and nocardiosis; chronic prostatitis;<br />

as prophylaxis in neutropenic patients with P. carinii infections, in leukemics, and in<br />

patients following renal transplantation, to decrease incidence of gram-negative rod<br />

infections<br />

Pregnancy Risk Factor<br />

C; D<br />

Contraindications<br />

Hypersensitivity to any sulfa drug or any component; porphyria; megaloblastic anemia due<br />

to folate deficiency; infants 10%:<br />

Dermatologic: Allergic skin reactions including rashes and urticaria, photosensitivity<br />

Gastrointestinal: Nausea, vomiting, anorexia.<br />

1% to 10%:


Dermatologic: Stevens-Johnson syndrome, toxic epidermal necrolysis (rare).<br />

Hematologic: Blood dyscrasias.<br />

Hepatic: Hepatitis .<br />


per kg body mass daily which approximately corresponds to the following dosage according to age:<br />

Children 6 - 12 years: Two medicine measures (10 mL) twice daily.<br />

In the treatment of acute infections, co-trimoxazole should be administered for at least 5 days or for<br />

at least 2 days after the symptoms have disappeared. If clinical improvement is not evident after<br />

7 days therapy, the patient should be reassessed.<br />

Patient Information<br />

Take oral medication with 8 oz of water on an empty stomach (1 hour before or 2 hours<br />

after meals) for best absorption. Finish all medication; do not skip doses. You may<br />

experience increased sensitivity to sunlight; use sunblock, wear protective clothing and<br />

dark glasses, or avoid direct exposure to sunlight. Small frequent meals, frequent mouth<br />

care, sucking lozenges, or chewing gum may reduce nausea or vomiting. Report skin rash,<br />

sore throat, blackened stool, or unusual bruising or bleeding immediately. Pregnancy<br />

precautions: Inform prescriber if you are or intend to be pregnant.<br />

LOMUS Drug Information Center<br />

<strong>Lomus</strong> <strong>Pharmaceuticals</strong> <strong>Pvt</strong>. <strong>Ltd</strong>.<br />

P.O. Box No 4506, <strong>Lomus</strong> House (Corporate office),<br />

Kailash Chour, Lazimpat, Kathmandu, Nepal<br />

Ph: 4436396 (Hunting Line). Fx: 977-1-4436395<br />

E-mail: druginfo@lomus.com.np

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!